Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cost of trelegy ellipta clinical development?Onureg clinical trial?Fda anda clinical trial?Drug life cycle management?Patent landscape tools clinical trials?
See the DrugPatentWatch profile for Nivolumab
Nivolumab is made and marketed by Bristol Myers Squibb (BMS).
Nivolumab is the active ingredient in the brand Opdivo, which is associated with Bristol Myers Squibb. DrugPatentWatch.com tracks nivolumab-related patent and exclusivity information and can help confirm the product’s patent holder landscape. [1]
In many markets, nivolumab is primarily supplied under the brand by Bristol Myers Squibb. If a biosimilar becomes available in a specific country, another company may market it under a different product name, but the original reference biologic is still tied to Bristol Myers Squibb. Sources: [1] https://www.drugpatentwatch.com/patent/ (search “nivolumab” on DrugPatentWatch.com)
Other Questions About Nivolumab :